A new Translational Imaging Center has just opened at the global headquarters of MPI Research in Mattawan, MI, the result of an alliance forged between MPI Research, inviCRO, and 3D Imaging. The new 10,000-square foot, two-story facility is dedicated to accelerating pharmaceutical discovery and development to benefit patients in need of new and improved therapeutics. Ground was broken for the facility in September of 2013.

The Center features the first commercially available cyclotron, which arrived on the site in February and which MPI says can speed up the drug development process by allowing researchers to use radioisotopes in molecular imaging to track therapeutic candidates' efficiency and distribution. Per the alliance, MPI Research is providing contract research services, inviCRO is bringing its imaging services and software solutions, and 3D Imaging will operate the cyclotron in addition to providing its knowledge base and experience with custom tracers in different animal models. 

“Bringing our three teams together has generated a one-of-a-kind suite of services that can’t be found anywhere else,” said Jack Hoppin, Ph.D., inviCRO's co-founder and managing partner, in a statement. “And this is just the beginning. We look forward to many ventures ahead as we continue to collaborate and draw on the strengths of each of our organizations.” 

Previous articleGamida Loses “Major Pharma” Buyer Said to Be Novartis
Next articleGENESIS™ Precision Genome Editing with CRISPR and rAAV